ILMN - ILLUMINA, INC.

128.97
-0.590   -0.457%

Share volume: 1,306,732
Last Updated: 03-04-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$129.56
-0.59
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
63%
Profitability 63%
Dept financing 39%
Liquidity 50%
Performance 71%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.95%
1 Month
-3.47%
3 Months
0.01%
6 Months
30.36%
1 Year
50.51%
2 Year
-4.24%
Key data
Stock price
$128.97
P/E Ratio 
24.26
DAY RANGE
$128.60 - $132.28
EPS 
$5.45
52 WEEK RANGE
$68.70 - $155.53
52 WEEK CHANGE
$52.36
MARKET CAP 
20.620 B
YIELD 
N/A
SHARES OUTSTANDING 
152.900 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-31-2025
BETA 
1.07
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,340,560
AVERAGE 30 VOLUME 
$2,534,529
Company detail
CEO: Francis A. deSouza
Region: US
Website: illumina.com
Employees: 11,500
IPO year: 2000
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and Asia-Pacific region.

Recent news